Intracellular expression of inflammatory proteins S100A8 and S100A9 leads to epithelial-mesenchymal transition and attenuated aggressivity of breast cancer cells

Anti-Cancer Agents in Medicinal Chemistry

Volumn 14, Issue 1, 2014, Pages 35-45

  Cormier, Kevin ^a,b   Harquail, Jason ^a,b   Ouellette, Rodney J ^a,b   Tessier, Philippe A ^c   Guerrette, Roxann ^a,b   Robichaud, Gilles A ^a,b  

^a UNIVERSITÉ DE MONCTON   (Canada)

^b ATLANTIC CANCER RESEARCH INSTITUTE   (Canada)

^c Université Laval   (Canada)

Author keywords

Breast cancer; EMT MET; FAK; Invasion; Metastasis; Myeloid related proteins; S100A8; S100A9

Indexed keywords

ALPHA5 INTEGRIN; CALGRANULIN A; CALGRANULIN B; FOCAL ADHESION KINASE 1; PROTEIN ZO1; TRANSCRIPTION FACTOR PAX5; UVOMORULIN;

ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER INHIBITION; CELL ADHESION; CELL INVASION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; METASTASIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR INVASION; WESTERN BLOTTING;

B-CELL-SPECIFIC ACTIVATOR PROTEIN; BREAST NEOPLASMS; CADHERINS; CALGRANULIN A; CALGRANULIN B; CELL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; NEOPLASM INVASIVENESS; RECOMBINANT PROTEINS; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84899452385     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/18715206113136660333     Document Type: Article

References (83)

1. Chao, Y.L.; Shepard, C. R.; Wells, A. Breast carcinoma cells re- express E-cadherin during mesenchymal to epithelial reverting transition. Mol. Cancer, 2010, 9, 179.
2. Wells, A.; Yates, C.; Shepard, C.R. E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas. Clin. Exp. Metastasis, 2008, 25(6), 621-628.
3. Yao, D.; Dai, C.; Peng, S. Mechanism of mesenchymal-epithelial transition and the relationship with metastatic tumor formation. Mol. Cancer Res., 2011, 9, 1541-7786.
4. Berx, G.; Van Roy, F. The E-cadherin/catenin complex: An important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res., 2001, 3(5), 289-293.
5. Cavallaro, U. N-cadherin as an invasion promoter: A novel target for antitumor therapy? Curr. Opin. Investig. Drugs, 2004, 5(12), 1274-1278.
6. Onder, T.T.; Gupta, P.B.; Mani, S.A.; Yang, J.; Lander, E.S.; Weinberg, R.A. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res., 2008, 68(10), 3645-3654.
7. Lehembre, F.; Yilmaz, M.; Wicki, A.; Schomber, T.; Strittmatter, K.; Ziegler, D.; Kren, A.; Went, P.; Derksen, P.W.; Berns, A.; Jonkers, J.; Christofori, G. NCAM-induced focal adhesion assembly: a functional switch upon loss of E-cadherin. EMBO J., 2008, 27(19), 2603-2615.
8. Heimann, R.; Lan, F.; McBride, R.; Hellman, S. Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin. Cancer Res., 2000, 60(2), 298-304.
9. Hunt, N.C.; Douglas-Jones, A.G.; Jasani, B.; Morgan, J.M.; Pignatelli, M. Loss of E-cadherin expression associated with lymph node metastases in small breast carcinomas. Virchows Arch., 1997, 430(4), 285-289.
10. Golubovskaya, V.M.; Kweh, F.A.; Cance, W.G. Focal adhesion kinase and cancer. Histol. Histopathol., 2009, 24(4), 503-510.
11. Avizienyte, E.; Frame, M.C. Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition. Curr. Opin. Cell Biol., 2005, 17(5), 542-547.
12. Irby, R.B.; Yeatman, T.J. Increased Src activity disrupts cadherin/ catenin-mediated homotypic adhesion in human colon cancer and transformed rodent cells. Cancer Res., 2002, 62(9), 2669-2674.
13. Pylayeva, Y.; Gillen, K.M.; Gerald, W.; Beggs, H.E.; Reichardt, L.F.; Giancotti, F.G. Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling. J. Clin. Invest., 2009, 119(2), 252-266.
14. Lightfoot, H.M., Jr.; Lark, A.; Livasy, C.A.; Moore, D.T.; Cowan, D.; Dressler, L.; Craven, R.J.; Cance, W.G. Upregulation of focal adhesion kinase (FAK) expression in ductal carcinoma in situ (DCIS) is an early event in breast tumorigenesis. Breast Cancer Res. Treat., 2004, 88(2), 109-116.
15. Cance, W.G.; Harris, J.E.; Iacocca, M.V.; Roche, E.; Yang, X.; Chang, J.; Simkins, S.; Xu, L. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: Correlation with preinvasive and invasive phenotypes. Clin. Cancer Res., 2000, 6(6), 2417-2423.
16. Lark, A.L.; Livasy, C.A.; Dressler, L.; Moore, D.T.; Millikan, R.C.; Geradts, J.; Iacocca, M.; Cowan, D.; Little, D.; Craven, R.J.; Cance, W. High focal adhesion kinase expression in invasive breast carcinomas is associated with an aggressive phenotype. Mod. Pathol., 2005, 18(10), 1289-1294.
17. Zhang, S.; Wang, G.; Liu, D.; Bao, Z.; Fernig, D.G.; Rudland, P.S.; Barraclough, R. The C-terminal region of S100A4 is important for its metastasis-inducing properties. Oncogene, 2005, 24(27), 4401-4411.
18. Yong, H.Y.; Moon, A. Roles of calcium-binding proteins, S100A8 and S100A9, in invasive phenotype of human gastric cancer cells. Arch. Pharm. Res., 2007, 30(1), 75-81.
19. Kawai, H.; Minamiya, Y.; Takahashi, N. Prognostic impact of S100A9 overexpression in non-small cell lung cancer. Tumour Biol., 2011, 32(4), 641-646.
20. Wang, G.; Zhang, S.; Fernig, D.G.; Martin-Fernandez, M.; Rudland, P.S.; Barraclough, R. Mutually antagonistic actions of S100A4 and S100A1 on normal and metastatic phenotypes. Oncogene, 2005, 24(8), 1445-1454.
21. Bulk, E.; Sargin, B.; Krug, U.; Hascher, A.; Jun, Y.; Knop, M.; Kerkhoff, C.; Gerke, V.; Liersch, R.; Mesters, R. M.; Hotfilder, M.; Marra, A.; Koschmieder, S.; Dugas, M.; Berdel, W.E.; Serve, H.; Muller-Tidow, C. S100A2 induces metastasis in non-small cell lung cancer. Clin. Cancer Res., 2009, 15(1), 22-29.
22. Altwegg, L. A.; Neidhart, M.; Hersberger, M.; Muller, S.; Eberli, F. R.; Corti, R.; Roffi, M.; Sutsch, G.; Gay, S.; von Eckardstein, A.; Wischnewsky, M. B.; Luscher, T. F.; Maier, W. Myeloid-related protein 8/14 complex is released by monocytes and granulocytes at the site of coronary occlusion: A novel, early, and sensitive marker of acute coronary syndromes. Eur. Heart J., 2007, 28(8), 941-948.
23. Benaud, C.; Gentil, B. J.; Assard, N.; Court, M.; Garin, J.; Delphin, C.; Baudier, J. AHNAK interaction with the annexin 2/S100A10 complex regulates cell membrane cytoarchitecture. J. Cell Biol., 2004, 164(1), 133-144.
24. Baillet, A.; Trocme, C.; Berthier, S.; Arlotto, M.; Grange, L.; Chenau, J.; Quetant, S.; Seve, M.; Berger, F.; Juvin, R.; Morel, F.; Gaudin, P. Synovial fluid proteomic fingerprint: S100A8, S100A9 and S100A12 proteins discriminate rheumatoid arthritis from other inflammatory joint diseases. Rheumatology (Oxford), 2010, 49(4), 671-682.
25. Shepherd, C.E.; Goyette, J.; Utter, V.; Rahimi, F.; Yang, Z.; Geczy, C.L.; Halliday, G.M., Inflammatory S100A9 and S100A12 proteins in Alzheimer's disease. Neurobiol. Aging, 2006, 27(11), 1554-1563.
26. Ryckman, C.; McColl, S.R.; Vandal, K.; de Médicis, R.; Lussier, A.; Poubelle, P.E.; Tessier, P.A. Role of S100A8 and S100A9 in neutrophil recruitment in response to monosodium urate monohydrate crystals in the air-pouch model of acute gouty arthritis. Arthritis & Rheumatism, 2003, 48(8), 2310-2320.
27. Jenkinson, S.R.; Barraclough, R.; West, C.R.; Rudland, P.S. S100A4 regulates cell motility and invasion in an in vitro model for breast cancer metastasis. Br. J. Cancer, 2004, 90(1), 253-262.
28. Bartling, B.; Rehbein, G.; Schmitt, W.D.; Hofmann, H.S.; Silber, R. E.; Simm, A. S100A2-S100P expression profile and diagnosis of non-small cell lung carcinoma: impairment by advanced tumour stages and neoadjuvant chemotherapy. Eur. J. Cancer, 2007, 43(13), 1935-1943.
29. Burkhardt, K.; Radespiel-Troger, M.; Rupprecht, H.D.; Goppelt-Struebe, M.; Riess, R.; Renders, L.; Hauser, I. A.; Kunzendorf, U. An increase in myeloid-related protein serum levels precedes acute renal allograft rejection. J. Am. Soc. Nephrol., 2001, 12(9), 1947-1957.
30. Chen, Y.S.; Yan, W.; Geczy, C.L.; Brown, M.A.; Thomas, R. Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis. Arthritis. Res. Ther., 2009, 11(2), R39.
31. Ryckman, C.; Vandal, K.; Rouleau, P.; Talbot, M.; Tessier, P.A. Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J. Immunol., 2003, 170(6), 3233-3242.
32. Boyd, J.H.; Kan, B.; Roberts, H.; Wang, Y.; Walley, K.R. S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products. Circ. Res., 2008, 102(10), 1239-1246.
33. Moon, A.; Yong, H.Y.; Song, J.I.; Cukovic, D.; Salagrama, S.; Kaplan, D.; Putt, D.; Kim, H.; Dombkowski, A.; Kim, H.R.C. Global gene expression profiling unveils S100A8/A9 as candidate markers in h-ras-mediated human breast epithelial cell invasion. Mol. Cancer Res., 2008, 6(10), 1544-1553.
34. Koskimaa, H.M.; Kurvinen, K.; Costa, S.; Syrjanen, K.; Syrjanen, S. Molecular markers implicating early malignant events in cervical carcinogenesis. Cancer Epidemiol. Biomarkers Prev., 2010, 19(8), 2003-2012.
35. Kim, H.J.; Kang, H.J.; Lee, H.; Lee, S.T.; Yu, M.H.; Kim, H.; Lee, C. Identification of S100A8 and S100A9 as serological markers for colorectal cancer. J. Proteome Res., 2009, 8(3), 1368-1379.
36. Perez-Lorenzo, R.; Markell, L.M.; Hogan, K.A.; Yuspa, S.H.; Glick, A.B. Transforming growth factor beta1 enhances tumor promotion in mouse skin carcinogenesis. Carcinogenesis, 2010, 31(6), 1116-1123.
37. Cross, S.S.; Hamdy, F.C.; Deloulme, J.C.; Rehman, I. Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. Histopathology, 2005, 46(3), 256-269.
38. McKiernan, E.; McDermott, E.W.; Evoy, D.; Crown, J.; Duffy, M.J. The role of S100 genes in breast cancer progression. Tumour Biol., 2011, 32(3), 441-450.
39. Carlsson, H.; Yhr, M.; Petersson, S.; Collins, N.; Polyak, K.; Enerback, C. Psoriasin (S100A7) and calgranulin-B (S100A9) induction is dependent on reactive oxygen species and is downregulated by Bcl-2 and antioxidants. Cancer Biol. Ther., 2005, 4(9), 998-1005.
40. Arai, K.; Takano, S.; Teratani, T.; Ito, Y.; Yamada, T.; Nozawa, R. S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast. Curr. Cancer Drug Targets, 2008, 8(4), 243-252.
41. Parris, T.Z.; Danielsson, A.; Nemes, S.; Kovacs, A.; Delle, U.; Fallenius, G.; Mollerstrom, E.; Karlsson, P.; Helou, K. Clinical implications of gene dosage and gene expression patterns in diploid breast carcinoma. Clin. Cancer Res., 2010, 16(15), 3860-3874.
42. Seth, A.; Kitching, R.; Landberg, G.; Xu, J.; Zubovits, J.; Burger, A.M. Gene expression profiling of ductal carcinomas in situ and invasive breast tumors. Anticancer Res., 2003, 23(3A), 2043-2051.
43. Carlsson, H.; Petersson, S.; Enerback, C. Cluster analysis of S100 gene expression and genes correlating to psoriasin (S100A7) expression at different stages of breast cancer development. Int. J. Oncol., 2005, 27(6), 1473-1481.
44. Rhee, D.K.; Park, S.H.; Jang, Y.K. Molecular signatures associated with transformation and progression to breast cancer in the isogenic MCF10 model. Genomics, 2008, 92(6), 419-428.
45. Ryckman, C.; Robichaud, G.A.; Roy, J.; Cantin, R.; Tremblay, M.J.; Tessier, P.A. HIV-1 transcription and virus production are both accentuated by the proinflammatory myeloid-related proteins in human CD4+ T lymphocytes. J. Immunol., 2002, 169(6), 3307-3313.
46. Robichaud, G.A.; Nardini, M.; Laflamme, M.; Cuperlovic-Culf, M.; Ouellette, R.J. Human Pax-5 C-terminal isoforms possess distinct transactivation properties and are differentially modulated in normal and malignant B cells. J. Biol. Chem., 2004, 279(48), 49956-49963.
47. Liu, Y.N.; Lee, W.W.; Wang, C.Y.; Chao, T.H.; Chen, Y.; Chen, J.H. Regulatory mechanisms controlling human E-cadherin gene expression. Oncogene, 2005, 24(56), 8277-8290.
48. Qin, L.; Chen, X.; Wu, Y.; Feng, Z.; He, T.; Wang, L.; Liao, L.; Xu, J. Steroid receptor coactivator-1 upregulates integrin alpha(5) expression to promote breast cancer cell adhesion and migration. Cancer Res., 2011, 71(5), 1742-1751.
49. Nutt, S.L.; Morrison, A.M.; Dorfler, P.; Rolink, A.; Busslinger, M. Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments. EMBO J., 1998, 17(8), 2319-2333.
50. Livak, K.J.; Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 2001, 25(4), 402-408.
51. Vidal, L.J.; Perry, J.K.; Vouyovitch, C.M.; Pandey, V.; Brunet-Dunand, S.E.; Mertani, H. C.; Liu, D.X.; Lobie, P.E. PAX5alpha enhances the epithelial behavior of human mammary carcinoma cells. Mol. Cancer Res., 2010, 8(3), 444-456.
52. Arai, K.; Teratani, T.; Kuruto-Niwa, R.; Yamada, T.; Nozawa, R. S100A9 expression in invasive ductal carcinoma of the breast: S100A9 expression in adenocarcinoma is closely associated with poor tumour differentiation. Eur. J. Cancer, 2004, 40(8), 1179-1187.
53. Hermani, A.; Servi, B.D.; Medunjanin, S.; Tessier, P. A.; Mayer, D. S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Exp.Cell Res., 2006, 312(2), 184-197.
54. Turovskaya, O.; Foell, D.; Sinha, P.; Vogl, T.; Newlin, R.; Nayak, J.; Nguyen, M.; Olsson, A.; Nawroth, P. P.; Bierhaus, A.; Varki, N.; Kronenberg, M.; Freeze, H.H.; Srikrishna, G. RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis. Carcinogenesis, 2008, 29(10), 2035-2043.
55. Ghavami, S.; Rashedi, I.; Dattilo, B.M.; Eshraghi, M.; Chazin, W.J.; Hashemi, M.; Wesselborg, S.; Kerkhoff, C.; Los, M. S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. J. Leukoc. Biol., 2008, 83(6), 1484-1492.
56. Qin, F.; Song, Y.; Li, Z.; Zhao, L.; Zhang, Y.; Geng, L. S100A8/A9 induces apoptosis and inhibits metastasis of CasKi human cervical cancer cells. Pathol. Oncol. Res., 2010, 16(3), 353-360.
57. Ghavami, S.; Kerkhoff, C.; Chazin, W.J.; Kadkhoda, K.; Xiao, W.; Zuse, A.; Hashemi, M.; Eshraghi, M.; Schulze-Osthoff, K.; Klonisch, T.; Los, M. S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2. Biochim. Biophys. Acta, 2008, 1783(2), 297-311.
58. Ghavami, S.; Eshragi, M.; Ande, S.R.; Chazin, W.J.; Klonisch, T.; Halayko, A.J.; McNeill, K.D.; Hashemi, M.; Kerkhoff, C.; Los, M. S100A8/A9 induces autophagy and apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes that involves BNIP3. Cell Res., 2010, 20(3), 314-331.
59. Vogl, T. MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes. Blood, 2004, 104(13), 4260-4268.
60. Keibel, A.; Singh, V.; Sharma, M.C. Inflammation, micro-environment, and the immune system in cancer progression. Curr. Pharm. Des., 2009, 15(17), 1949-1955.
61. Lee, H.; O'Meara, S.J.; O'Brien, C.; Kane, R. The role of gremlin, a BMP antagonist, and epithelial-to-mesenchymal transition in proliferative vitreoretinopathy. Invest. Ophthalmol. Vis. Sci., 2007, 48(9), 4291-4299.
62. Reichert, M.; Muller, T.; Hunziker, W. The PDZ domains of zonula occludens-1 induce an epithelial to mesenchymal transition of Madin-Darby canine kidney I cells. Evidence for a role of beta-catenin/Tcf/Lef signaling. J. Biol. Chem., 2000, 275(13), 9492-9500.
63. Baranwal, S.; Alahari, S.K. Molecular mechanisms controlling E-cadherin expression in breast cancer. Biochem. Biophys. Res. Commun., 2009, 384(1), 6-11.
64. Conacci-Sorrell, M.; Simcha, I.; Ben-Yedidia, T.; Blechman, J.; Savagner, P.; Ben-Ze'Ev, A. Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, SLUG, and MAPK. J. Cell Biol., 2003, 163(4), 847-857.
65. Perl, A. K.; Wilgenbus, P.; Dahl, U.; Semb, H.; Christofori, G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature, 1998, 392(6672), 190-193.
66. Cano, A.; Perez-Moreno, M.A.; Rodrigo, I.; Locascio, A.; Blanco, M. J.; del Barrio, M.G.; Portillo, F.; Nieto, M.A. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol., 2000, 2(2), 76-83.
67. Storci, G.; Sansone, P.; Mari, S.; D'Uva, G.; Tavolari, S.; Guarnieri, T.; Taffurelli, M.; Ceccarelli, C.; Santini, D.; Chieco, P.; Marcu, K. B.; Bonafe, M. TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype. J. Cell Physiol., 2010, 225(3), 682-691.
68. Chua, H.L.; Bhat-Nakshatri, P.; Clare, S.E.; Morimiya, A.; Badve, S.; Nakshatri, H. NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. Oncogene, 2007, 26(5), 711-724.
69. Vesuna, F.; Van Diest, P.; Chen, J.H.; Raman, V. Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. Biochem. Biophys. Res. Commun., 2008, 367(2), 235-241.
70. Huber, M.A.; Azoitei, N.; Baumann, B.; Grunert, S.; Sommer, A.; Pehamberger, H.; Kraut, N.; Beug, H.; Wirth, T. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J. Clin. Invest., 2004, 114(4), 569-581.
71. Cicchini, C.; Laudadio, I.; Citarella, F.; Corazzari, M.; Steindler, C.; Conigliaro, A.; Fantoni, A.; Amicone, L.; Tripodi, M., TGFbeta-induced EMT requires focal adhesion kinase (FAK) signaling. Exp. Cell. Res., 2008, 314(1), 143-152.
72. Schaller, M.D. Paxillin: A focal adhesion-associated adaptor protein. Oncogene, 2001, 20(44), 6459-6472.
73. Bellis, S.L.; Miller, J.T.; Turner, C.E. Characterization of tyrosine phosphorylation of paxillin in vitro by focal adhesion kinase. J. Biol. Chem., 1995, 270(29), 17437-17441.
74. Shi, J.; Wang, S.; Zhao, E.; Shi, L.; Xu, X.; Fang, M. Paxillin expression levels are correlated with clinical stage and metastasis in salivary adenoid cystic carcinoma. J. Oral Pathol. Med., 2010, 39(7), 548-551.
75. Bertolucci, C.M.; Guibao, C.D.; Zheng, J. Structural features of the focal adhesion kinase-paxillin complex give insight into the dynamics of focal adhesion assembly. Protein Sci., 2005, 14(3), 644-652.
76. Deakin, N.O.; Turner, C.E. Paxillin comes of age. J. Cell Sci., 2008, 121(Pt 15), 2435-2444.
77. Liu, W.; Li, X.; Chu, E. S.; Go, M.Y.; Xu, L.; Zhao, G.; Li, L.; Dai, N.; Si, J.; Tao, Q.; Sung, J. J.; Yu, J. Paired box gene 5 is a novel tumor suppressor in hepatocellular carcinoma through interaction with p53 signaling pathway. Hepatology, 2011, 53(3), 843-853.
78. Kanteti, R.; Nallasura, V.; Loganathan, S.; Tretiakova, M.; Kroll, T.; Krishnaswamy, S.; Faoro, L.; Cagle, P.; Husain, A. N.; Vokes, E.E.; Lang, D.; Salgia, R. PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription. Lab Invest., 2009, 89(3), 301-314.
79. Ellsworth, R.E.; Seebach, J.; Field, L.A.; Heckman, C.; Kane, J.; Hooke, J.A.; Love, B.; Shriver, C.D. A gene expression signature that defines breast cancer metastases. Clin. Exp. Metastasis, 2009, 26(3), 205-213.
80. Crapoulet, N.; O'Brien, P.; Ouellette, R.J.; Robichaud, G.A. Coordinated expression of Pax-5 and FAK1 in metastasis. Anticancer Agents Med. Chem., 2011, 11(7), 643-649.
81. Chaffer, C.L.; Brennan, J.P.; Slavin, J.L.; Blick, T.; Thompson, E. W.; Williams, E.D. Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. Cancer Res., 2006, 66(23), 11271-11278.
82. Hiratsuka, S.; Watanabe, A.; Sakurai, Y.; Akashi-Takamura, S.; Ishibashi, S.; Miyake, K.; Shibuya, M.; Akira, S.; Aburatani, H.; Maru, Y. The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase. Nat. Cell Biol., 2008, 10(11), 1349-1355.
83. Powell, A.A.; Talasaz, A.H.; Zhang, H.; Coram, M.A.; Reddy, A.; Deng, G.; Telli, M.L.; Advani, R.H.; Carlson, R.W.; Mollick, J.A.; Sheth, S.; Kurian, A.W.; Ford, J.M.; Stockdale, F.E.; Quake, S.R.; Pease, R.F.; Mindrinos, M.N.; Bhanot, G.; Dairkee, S.H.; Davis, R.W.; Jeffrey, S.S. Single cell profiling of circulating tumor cells: Transcriptional heterogeneity and diversity from breast cancer cell lines. PLoS One, 2012, 7(5), e33788.